Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hypertensive encephalopathy
ADR ID BADD_A02153
ADR Hierarchy
17      Nervous system disorders
17.13      Encephalopathies
17.13.02      Encephalopathies NEC
17.13.02.002      Hypertensive encephalopathy
24      Vascular disorders
24.08      Vascular hypertensive disorders
24.08.05      Hypertension complications
24.08.05.001      Hypertensive encephalopathy
Description Brain dysfunction or damage resulting from sustained MALIGNANT HYPERTENSION. When BLOOD PRESSURE exceeds the limits of cerebral autoregulation, cerebral blood flow is impaired (BRAIN ISCHEMIA). Clinical manifestations include HEADACHE; NAUSEA; VOMITING; SEIZURES; altered mental status (in some cases progressing to COMA); PAPILLEDEMA; and RETINAL HEMORRHAGE. [MeSH]
MedDRA Code 10020803
MeSH ID D020343
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Encephalopathy hypertensive | Hypertensive encephalopathy | Hypertensive Encephalopathy | Encephalopathy, Hypertensive
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00041Adalimumab--
BADD_D00193Axitinib0.000799%
BADD_D00284Bortezomib0.000533%
BADD_D00589Dasatinib0.000533%
BADD_D01687Pazopanib0.000533%
BADD_D02100Sunitinib0.000533%
BADD_D02325Valdecoxib--
BADD_D02419Rosiglitazone0.000300%
The 1th Page    1    Total 1 Pages